SCHEMBL21670262

SCHEMBL21670262

NC(=O)C1CCCN(S(=O)(=O)c2ccccc2)C1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.70
SMN1; SMN2 Q16637 3/20 0.70
CYP2C19 P33261 1/20 0.65
AKR1C3 P42330 5/20 0.62
AKR1C1 Q04828 2/20 0.62
MAPT P10636 1/20 0.61
TSHR P16473 1/20 0.60
HTT P42858 1/20 0.60
ALDH1A1 P00352 3/20 0.59
HPGD P15428 1/20 0.59
MAPK1 P28482 1/20 0.59
L3MBTL1 Q9Y468 1/20 0.59
NPSR1 Q6W5P4 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4701073 0.88 MAPT (0.77) LMNASMN1; SMN2CYP2C19AKR1C3AKR1C1
SCHEMBL21669903 0.88 MAPT (0.77) LMNASMN1; SMN2CYP2C19AKR1C3AKR1C1
SCHEMBL610121 0.88 MAPT (0.77) LMNASMN1; SMN2CYP2C19AKR1C3AKR1C1
SCHEMBL19563515 0.86 MAPT (0.59) LMNASMN1; SMN2AKR1C3AKR1C1MAPT
SCHEMBL14538823 0.86 ALDH1A1 (0.70) LMNASMN1; SMN2MAPTALDH1A1MAPK1
SCHEMBL10282884 0.86 ALDH1A1 (0.70) LMNASMN1; SMN2MAPTALDH1A1MAPK1
SCHEMBL21670254 0.86 LMNA (0.70) LMNASMN1; SMN2CYP2C19AKR1C3AKR1C1
SCHEMBL21670261 0.86 LMNA (0.70) LMNASMN1; SMN2CYP2C19AKR1C3AKR1C1
SCHEMBL27791834 0.85 LMNA (0.52) LMNASMN1; SMN2CYP2C19HTTALDH1A1
SCHEMBL25269754 0.84 AKR1C3 (0.80) LMNASMN1; SMN2AKR1C3AKR1C1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4192816-A1 COMPOUNDS AS C5AR INHIBITORS Kira Pharmaceuticals (Suzhou) Ltd. (CN) 2023-06-14 EP disclosed
WO-2020028482-A1 SMALL MOLECULES THAT SENSITIZE HIV-1 INFECTED CELLS TO ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2020-02-06 WO disclosed